{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:15:55Z","timestamp":1778336155393,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ijrobp.2023.06.077","type":"journal-article","created":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T17:32:06Z","timestamp":1688923926000},"page":"1125-1137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Brachytherapy With 15- Versus 20-mm Ruthenium 106 Plaques Without Verification of Plaque Position Is Associated With Local Tumor Recurrence and Death in Posterior Uveal Melanoma"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-8911","authenticated-orcid":false,"given":"Gustav","family":"St\u00e5lhammar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.06.077_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-022-00082-y","article-title":"Long-term relative survival in uveal melanoma: A systematic review and meta-analysis","volume":"2","author":"St\u00e5lhammar","year":"2022","journal-title":"Commun Med"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2022.926034","article-title":"Trends in uveal melanoma presentation and survival during five decades: A nationwide survey of 3898 Swedish patients","volume":"9","author":"Gill","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0004","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: Trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0006","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4143\/crt.2016.391","article-title":"Ruthenium-106 brachytherapy with or without additional local therapy shows favorable outcome for variable-sized choroidal melanomas in Korean patients","volume":"50","author":"Cho","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000492391","article-title":"Uveal melanoma in Ireland","volume":"5","author":"Baily","year":"2019","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0008","first-page":"5281","article-title":"Brachytherapy of uveal melanomas with ruthenium-106 plaques","volume":"17","author":"Bela\u00efd","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0009","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","article-title":"Local treatment failure after globe-conserving therapy for choroidal melanoma","volume":"97","author":"Chang","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0010","first-page":"280","article-title":"Uveal melanoma in Israel in the last two decades: Characterization, treatment and prognosis","volume":"11","author":"Frenkel","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0011","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12886-022-02521-9","article-title":"Ruthenium-106 plaque radiotherapy for uveal melanoma: Analysis of tumor dimension and location on anatomical and functional results","volume":"22","author":"Mirshahi","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0012","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.prro.2013.08.004","article-title":"Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma","volume":"4","author":"Takiar","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0013","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.prro.2014.09.005","article-title":"A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma","volume":"5","author":"Takiar","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0014","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bjo.2009.157701","article-title":"Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas","volume":"93","author":"Kaiserman","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/bjophthalmol-2018-313419","article-title":"Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of >\/=5.5 mm","volume":"104","author":"Fili","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000362560","article-title":"Monte Carlo simulation of the treatment of eye tumors with (106)Ru plaques: A study on maximum tumor height and eccentric placement","volume":"1","author":"Brualla","year":"2014","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0017","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2017.01.010","article-title":"Treatment plan optimization and robustness of (106)Ru eye plaque brachytherapy using a novel software tool","volume":"123","author":"Heilemann","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0018","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000456717","article-title":"Monte Carlo estimation of absorbed dose distributions obtained from heterogeneous 106Ru eye plaques","volume":"3","author":"Zaragoza","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0019","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/bjophthalmol-2014-305055","article-title":"High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome","volume":"98","author":"Fili","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bjophthalmol-2019-315722","article-title":"Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma","volume":"105","author":"Fili","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"American Brachytherapy Society. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0022","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archophthalmol.2007.9","article-title":"Tilting of radioactive plaques after initial accurate placement for treatment of uveal melanoma","volume":"126","author":"Almony","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0023","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1259\/bjr\/76813976","article-title":"Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (<or=5 mm) choroidal melanoma lesions","volume":"81","author":"Wilkinson","year":"2008","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0024","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.brachy.2014.04.002","article-title":"(106)Ru plaque brachytherapy for uveal melanoma: Factors associated with local tumor recurrence","volume":"13","author":"Barker","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2005.02.017","article-title":"Local tumor control after 106Ru brachytherapy of choroidal melanoma","volume":"63","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0026","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ophtha.2020.06.057","article-title":"Brachytherapy of choroidal melanomas less than 10 mm in largest basal diameter: Comparison of 10-mm and 15-mm ruthenium plaques","volume":"128","author":"Jouhi","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0027","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00417-012-1962-3","article-title":"Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma","volume":"250","author":"Russo","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0028","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2217\/fon-2020-1193","article-title":"Risk tolerance in adjuvant and metastatic melanoma settings: A patient perspective study using the threshold technique","volume":"17","author":"Mansfield","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0029","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Ophthalmic Oncology Task Force. Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0030","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0161-6420(91)32193-6","article-title":"Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy","volume":"98","author":"Vrabec","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0031","first-page":"43","article-title":"Long-term risk of local failure after proton therapy for choroidal\/ciliary body melanoma","volume":"100","author":"Gragoudas","year":"2002","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0032","doi-asserted-by":"crossref","first-page":"11297","DOI":"10.1038\/s41598-020-68232-7","article-title":"Forty-year prognosis after plaque brachytherapy of uveal melanoma","volume":"10","author":"St\u00e5lhammar","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0033","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.brachy.2021.05.162","article-title":"Long-term outcomes after enucleation or plaque brachytherapy of choroidal melanomas touching the optic disc","volume":"20","author":"Fili","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0034","series-title":"Uveal Melanoma AJCC Cancer Staging Manual","author":"Kivel\u00e4","year":"2017"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0036","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/aos.15210","article-title":"A prognostic classification system for uveal melanoma based on a combination of patient age and sex, the American Joint Committee on Cancer and the cancer genome atlas models","volume":"101","author":"Gill","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0037","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: An easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0038","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000479558","article-title":"Dose distributions and treatment margins in ocular brachytherapy with 106Ru eye plaques","volume":"4","author":"St\u00f6ckel","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0039","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ophtha.2010.06.007","article-title":"Plaque radiotherapy for juxtapapillary choroidal melanoma: Tumor control in 650 consecutive cases","volume":"118","author":"Sagoo","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0040","article-title":"A prognostic score for the prediction of local treatment failure in plaque brachytherapy of uveal melanoma","volume":"8","author":"R","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0041","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ophtha.2023.03.010","article-title":"Genetic status affects disease-specific mortality but not the incidence of local recurrence in patients with uveal melanoma","volume":"130","author":"Bagger","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0042","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0043","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: Tumor progression before and after treatment","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0044","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0161-6420(00)00607-2","article-title":"Uveal melanoma: Implications of tumor doubling time","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0045","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1038\/s41598-021-88390-6","article-title":"Estimation of the timing of BAP1 mutation in uveal melanoma progression","volume":"11","author":"Uner","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0046","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ajcp\/aqad029","article-title":"Multiorgan involvement of dormant uveal melanoma micrometastases in postmortem tissue from patients without coexisting macrometastases","volume":"160","author":"Gill","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103652","article-title":"The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis","volume":"172","author":"St\u00e5lhammar","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0048","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2796.1997.00178.x","article-title":"Declining autopsy rate in Sweden: A study of causes and consequences in Malmo, Sweden","volume":"242","author":"Lindstrom","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0049","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02841869509093948","article-title":"Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee","volume":"34","author":"Nystrom","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0050","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0051","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0052","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations","volume":"133","author":"Gupta","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ijrobp.2023.06.077_bib0053","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.joco.2018.02.005","article-title":"Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma","volume":"30","author":"Masoomian","year":"2018","journal-title":"J Curr Ophthalmol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623021971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623021971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:09:53Z","timestamp":1759745393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623021971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0360301623021971"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.06.077","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brachytherapy With 15- Versus 20-mm Ruthenium 106 Plaques Without Verification of Plaque Position Is Associated With Local Tumor Recurrence and Death in Posterior Uveal Melanoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.06.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}